Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CVS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CVS and 80,000+ other tickers.
See exactly how CVS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CVS and 80,000+ other tickers.
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The…
The company's community health investments are expanding access to housing, care and essential resources across the Commonwealth WOONSOCKET, R.I., July 22, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today highlighted its continued investments in improving the health of communities across Massachusetts, spanning affordable housing, collaborations with local nonprofit organizations and free health services.
Healthcare is quietly becoming the value hunter's playground of 2026. While the mega cap tech trade keeps sucking up oxygen, two of the largest healthcare names in the S&P 500 are trading at forward multiples that look mispriced against their earnings power.
Arvest Bank Trust Division increased its holdings in CVS Health Corporation (NYSE: CVS) by 2,401.7% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 66,945 shares of the pharmacy operator's stock after acquiring an additional 64,269 shares during the quarter. Arvest Bank
Bessemer Group Inc. boosted its holdings in shares of CVS Health Corporation (NYSE: CVS) by 34.9% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 35,994 shares of the pharmacy operator's stock after acquiring an additional 9,320 shares during the quarter. Bessemer
The latest trading day saw CVS Health (CVS) settling at $110.6, representing a +2.78% change from its previous close.